Neuroimaging holds promise in mental health
Neuroimaging technology has been shown to hold great promise in helping clinicians link specific symptoms of mental health disorders to abnormal patterns of brain activity....
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
Neuroimaging technology has been shown to hold great promise in helping clinicians link specific symptoms of mental health disorders to abnormal patterns of brain activity....
UConn Health and The Jackson Laboratory for Genomic Medicine have been collaborating on brain tumor genomic sequencing for the last five years. Most recently, they’re employing a methylome profiling...
An experimental dementia drug slowed clinical decline in people with early-stage Alzheimer’s disease in a phase 3 clinical trial, a new study shows. “This is...
The FDA has issued draft guidance to help pharmaceutical companies enroll more participants from underrepresented populations into clinical trials. That’s a challenge that New Haven-based Jumo...
View this email in your browser January 5, 2023 Registration for the STEM Career Expo is open! Meet hundreds of qualified students and alumni that...
Stamford-based SpringWorks Therapeutics has announced the completion of the submission of its new drug application to the Food and Drug Administration for Nirogacestat, an oral medicine for...
Tony Sheridan is President & CEO of the Chamber of Commerce of Eastern Connecticut. Writing in a Viewpoints column in the CT Mirror, he says:...
A California bioscience company has acquired Branford’s IsoPlexis in an all-stock transaction valued at $57.8 million. Berkeley Lights, based in Emeryville, Calif., said it intends to combine...
Guilford-based medical technology company Quantum-Si has made its “Platinum” technology commercially available. The company said Platinum provides next-generation, single-molecule protein sequencing. The technology can be used for...
Cybrexa Therapeutics has appointed Dr. Michael N. Needle as Chief Medical Officer. A board-certified hematologist/oncologist, Dr. Needle will be responsible for overseeing and strategizing the continued...